Clinical evaluation of the cobas® MTB-RIF/INH reagent and the cobas® 6800 for the detection of isoniazid and rifampicin resistance-Reference-Cited by-同舟云学术

Clinical evaluation of the cobas® MTB-RIF/INH reagent and the cobas® 6800 for the detection of isoniazid and rifampicin resistance

Published:2022-05 Issue: Volume:134 Page:102199
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Aono Akio^ORCID,Murase Yoshiro,Minegishi Masaaki,Ohtawa Shuichi,Yano Masatoshi,Chikamatsu Kinuyo^ORCID,Shimomura Yoshiko,Hosoya Makiko,Igarashi Yuriko^ORCID,Morishige Yuta,Yamada Hiroyuki^ORCID,Takaki Akiko^ORCID,Togashi Kenichi,Hiura Mikako,Mitarai Satoshi^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference26 articles.

1. Global tuberculosis Report 2020;World Health Organization,2020

2. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection;World Health Organization,2020

3. GLI model TB diagnostic algorithms;Global laboratory initiative,2018

4. Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis;Arentz;PLoS One,2013

5. Handbook on tuberculosis laboratory diagnostic methods in the European union – updated 2018;European Centre for Disease Prevention and Control,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two cases of iatrogenic levofloxacin-resistant pre-XDR tuberculosis in Japan;Journal of Infection and Chemotherapy;2024-08

2. Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis;Tuberculosis;2024-07

3. Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing;Frontiers in Tuberculosis;2024-01-05